About
Clinical Research
Areas of Focus
Categories
Clinical ResearchClinical ResearchClinical ResearchClinical ResearchClinical ResearchCg RegulatoryClinical ResearchVirginia, DC, DE & Maryland
Clinical Trials (30)
View allTotal Trials
30
As Lead Sponsor
0
As Collaborator
30
Total Enrollment
58,926
By Phase
PHASE2: 15NA: 2PHASE1/PHASE2: 4PHASE1: 3PHASE2/PHASE3: 2PHASE3: 1
By Status
COMPLETED: 11TERMINATED: 6RECRUITING: 4UNKNOWN: 3SUSPENDED: 2NOT_YET_RECRUITING: 1WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline29 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT05494697Collaborator
Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC
PHASE2Suspended
90 participants
Started: Jun 30, 2026 · Completed: Jan 31, 2030
NCT07116174Collaborator
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Different Wound Types
NANot yet recruiting
100 participants
Started: Aug 15, 2025 · Completed: Aug 15, 2026
NCT06828666Collaborator
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
PHASE1/PHASE2Recruiting
42 participants
Started: May 5, 2025 · Completed: Apr 30, 2026
NCT05592418Collaborator
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
PHASE2Completed
80 participants
Started: Jun 30, 2023 · Completed: Nov 30, 2023
NCT05571969Collaborator
Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors
PHASE1Suspended
40 participants
Started: Feb 20, 2023 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Germantown, MD, United States
Map
Loading map...